Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
作者信息
Teng Fei, Zhang Ju-Xiang, Chang Qi-Meng, Wu Xu-Bo, Tang Wei-Guo, Wang Jian-Fa, Feng Jin-Feng, Zhang Zi-Ping, Hu Zhi-Qiu
机构信息
Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China.
Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, 201199, People's Republic of China.
出版信息
J Exp Clin Cancer Res. 2020 Dec 9;39(1):277. doi: 10.1186/s13046-020-01780-y.
Abstract
摘要
Zotero 插件